BIOTECHNOLOGY PHARMACEUTICAL RESEARCH

Brand Owner (click to sort) Address Description
PHOSMAP Protana Inc. 251 ATTWELL DRIVE TORONTO, ONTARIO M9W 7H4 Canada BIOTECHNOLOGY AND PHARMACEUTICAL RESEARCH FOR OTHERS, NAMELY, DEVELOPING ASSAYS FOR THE DIAGNOSIS OF DISEASE AND DISEASE PROGRESSION AND FOR THE IDENTIFICATION AND MONITORING OF THE EFFECTS OF DRUG ADMINISTRATION VIA THE MONITORING OF PHOSPHORYLATION-RELATED BIOLOGICAL EVENTS; DEVELOPING METHODOLOGIES FOR BIOCHEMICAL RESEARCH TO BE USED FOR THE MONITORING OF PHOSPHORYLATION-RELATED BIOLOGICAL EVENTS, NAMELY DEVELOPING MARKERS USED TO DETERMINE THE PRESENCE OF DISEASE STATES, DISEASE PROGRESSION, AND EFFECTIVENESS OF DISEASE TREATMENT; DETERMINING BIOLOGICAL PHOSPHORYLATION-RELATED TARGETS FOR DRUGS; DETERMINING PHOSPHORYLATION-RELATED BIOLOGICAL PROCESSES OR PHOSPHORYLATION-RELATED BIOLOGICAL TARGETS WHICH ARE SUSCEPTIBLE TO BEING AFFECTED BY DRUGS; DEVELOPING METHODOLOGIES IN THE FIELD OF PHOSPHORYLATION-RELATED BIOLOGICAL EVENTS AND OR INSTRUMENTS RELATING THERETO IN THE FOREGOING SERVICES;
SCRIBE Message Pharmaceuticals, Inc. 30 Spring Mill Drive Malvern PA 19355 biotechnology and pharmaceutical research for others, namely, identifying important genes regulated by RNA-protein interactions, developing assays to identify small molecule drugs to alter the interactions; and designing and developing drugs as potential therapeutic agents;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. This invention relates to a method of producing a starch with unique functionality in plants through mutableness, and/or using biotechnology, and/or breeding practices. Further the invention relates to the starch from maize plants and/or other plants which produce starch storing organs which contain low amylose starch which has an amylose content between 1.5% and 15% and preferably between 1.5% and 10% and most preferably 1.5 and 8%. The invention includes starch extracted from such grain due to at least one mutation induced by ethyl methanesulfonate. Additionally, the invention uses a biotechnology approach involving controlling the activity of the granule bound starch synthase enzyme in starch storing organ. The invention includes the use of the starch for its cooking, paste, and gel properties.